Loading...
Last update:  October 15, 2017
12:47 +1GMT

Allergenic Molecule  Ara h 2Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8610.46020101214, Gadisseur R
1.10 - Any allergy symptom, Diagnosed2010FranceIgE6114.75020100923, Codrenau F
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE762.60020131020, van Rhijn BD
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE961.04020120528, Patelis A
1.3 - Rhinitis, Diagnosed2013BrazilIgE1010.00020130912, Lacerda Araujo LM
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE205.00020091005, Ott H
1.5 - Atopic Dermatitis, Diagnosed2014NetherlandsIgE21110.90020140331, Rockmann H
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
3.1.1 - Source Sensitized (SPT)2012SpainIgE7921.52020121016, Javaloyes G
3.1.4 - Source Sensitized (SPT, IgE)2013NetherlandsIgE2231.82020130429, Aalberse JA
3.1.4 - Source Sensitized (SPT, IgE)2012SpainIgE681.50020120726, Pedrosa M
3.2.1 - Source Sensitized (IgE)2014GermanyIgE2725.92020140225, Lopes de Oliveira LC
3.2.1 - Source Sensitized (IgE)2013ItalyIgE2412.00020131128, Calamelli E
3.2.1 - Source Sensitized (IgE)2013SloveniaIgE1631.20020131106, Homsak M
3.2.1 - Source Sensitized (IgE)2010SwedenIgE10053.00020100212, Asarnoj A
3.2.1 - Source Sensitized (IgE)2013ThailandIgE214.80020131011, Suratannon N
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)2011ChinaIgE1000.00020111214, Zheng YW
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE220.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2006GermanyIgE1662.50020060711, Lin J
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE200.00020091121, Ebo DG
4.1.5 - Heterologous Source Sensitized (IgE)2010SwedenIgE500.00020100212, Asarnoj A
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE372.70220090826, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009ItalyIgE210.00020090808, Krause S
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2011NetherlandsIgE80.00020110304, Vissers YM
5.1.1 - Source Exposed (Symptoms)2007FranceIgE4793.60020071022, Bernard H
5.1.1 - Source Exposed (Symptoms)2013NetherlandsIgE3789.19020130428, Klemans RJ
5.2.1 - Source Exposed (Symptoms, SPT)2003FranceIgE5888.00020031107, Bernard H
5.3.1 - Source Exposed (Symptoms, IgE)2004AustraliaIgE7081.40020040904, Hales BJ
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9916.16020110223, De Knop KJ
5.3.1 - Source Exposed (Symptoms, IgE)2014GermanyIgE3293.75020140225, Lopes de Oliveira LC
5.3.1 - Source Exposed (Symptoms, IgE)2013ItalyIgE2442.00020131128, Calamelli E
5.3.1 - Source Exposed (Symptoms, IgE)2014JapanIgE16100.00020140623, Nozawa A
5.3.1 - Source Exposed (Symptoms, IgE)2013SloveniaIgE11100.00020131106, Homsak M
5.3.1 - Source Exposed (Symptoms, IgE)2010SpainIgE5042.00020101124, Vereda A
5.3.1 - Source Exposed (Symptoms, IgE)2011SwedenIgE7456.75020110701, Moverare R
5.3.1 - Source Exposed (Symptoms, IgE)2010SwedenIgE3574.30020101124, Vereda A
5.3.1 - Source Exposed (Symptoms, IgE)2013ThailandIgE1968.40020131011, Suratannon N
5.3.1 - Source Exposed (Symptoms, IgE)2010United StatesIgE3090.00020101124, Vereda A
5.3.2 - Source Exposed (Symptoms, high IgE)2012TaiwanIgE2965.50020120319, Lin YT
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013NetherlandsIgE4388.37020130429, Aalberse JA
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2011NetherlandsIgE12100.00020110304, Vissers YM
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2004Netherlands / SwitzerlandIgE1741.20020041204, Mittag D
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012SpainIgE5572.20020120726, Pedrosa M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2004NetherlandsIgE (IB)3281.20020040416, Koppelman SJ
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)2006FranceIgE30100.00020060630, Astier C
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)1999Not DefinedIgE (IB)4085.0001999, Kleber-Janke T
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)2006FranceSPT30100.00020060630, Astier C
5.7.2 - Source Exposed (Provocation Test - Ingestion)2010FranceIgE16695.78020100923, Codrenau F
5.7.2 - Source Exposed (Provocation Test - Ingestion)2013ItalyIgE4827.00020131128, Calamelli E
5.7.2 - Source Exposed (Provocation Test - Ingestion)2007NetherlandsIgE20100.00020070615, Flinterman AE
5.7.2 - Source Exposed (Provocation Test - Ingestion)2013Sweden / USAIgE16754.20020130113, Lieberman JA
5.7.2 - Source Exposed (Provocation Test - Ingestion)2011United KingdomIgE18100.00020110318, Anagnostou K
5.7.2 - Source Exposed (Provocation Test - Ingestion)2007NetherlandsSPT9100.00020070615, Flinterman AE
6.2 - General Population (Adults)2012SwedenIgE3710.00020120528, Patelis A
Developed by
Panservice